These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32967898)

  • 21. Electronic Syndromic Surveillance for Influenza-Like Illness Across Treatment Settings.
    Ridgway JP; Lauderdale D; Thisted R; Robicsek A
    Infect Control Hosp Epidemiol; 2017 Apr; 38(4):393-398. PubMed ID: 27989247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of influenza point-of-care testing and patient cohorting during a high-incidence season: a retrospective analysis of impact on infection prevention and control and clinical outcomes.
    Youngs J; Marshall B; Farragher M; Whitney L; Glass S; Pope C; Planche T; Riley P; Carrington D
    J Hosp Infect; 2019 Mar; 101(3):276-284. PubMed ID: 30471317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of influenza and RSV diagnostic from nasopharyngeal swabs by rapid fluorescent immunoassay (Sofia system) and rapid bedside testing (BinaxNOW) vs. conventional fluorescent immunoassay in a German university children's hospital.
    Rack-Hoch AL; Laniado G; Hübner J
    Infection; 2017 Aug; 45(4):529-532. PubMed ID: 28290129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza A testing and detection in patients admitted through emergency departments in Sydney during winter 2009: implications for rational testing.
    Jardine A; Conaty SJ; Cretikos MA; Su WY; Gosbell IB; van Hal SJ
    Med J Aust; 2010 Oct; 193(8):455-9. PubMed ID: 20955122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Rapid Influenza Molecular Testing on Management in Pediatric Acute Care Settings.
    El Feghaly RE; Nolen JD; Lee BR; Abraham G; Nedved A; Hassan F; Selvarangan R
    J Pediatr; 2021 Jan; 228():271-277.e1. PubMed ID: 32828881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of influenza A and B viruses with the Sofia analyzer: a novel, rapid immunofluorescence-based in vitro diagnostic device.
    Lewandrowski K; Tamerius J; Menegus M; Olivo PD; Lollar R; Lee-Lewandrowski E
    Am J Clin Pathol; 2013 May; 139(5):684-9. PubMed ID: 23596120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using a novel rapid viral test to improve triage of emergency department patients with acute respiratory illness during flu season.
    Pedersen CJ; Rogan DT; Yang S; Quinn JV
    J Clin Virol; 2018 Nov; 108():72-76. PubMed ID: 30261422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of health system protocol on patient qualification for influenza point-of-care testing.
    Wells T; Wright A; Hudson E; Gay T; McLeod H; Ghassemi E
    J Am Pharm Assoc (2003); 2021; 61(4S):S118-S122. PubMed ID: 33054986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the 2014-2015 influenza season on the activity of an academic emergency department.
    Beysard N; Yersin B; Meylan P; Hugli O; Carron PN
    Intern Emerg Med; 2018 Mar; 13(2):251-256. PubMed ID: 28091839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses.
    Poehling KA; Zhu Y; Tang YW; Edwards K
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):713-8. PubMed ID: 16818837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of point-of-care influenza testing on management of febrile children.
    Iyer SB; Gerber MA; Pomerantz WJ; Mortensen JE; Ruddy RM
    Acad Emerg Med; 2006 Dec; 13(12):1259-68. PubMed ID: 17079787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department.
    Kankaanpää M; Raitakari M; Muukkonen L; Gustafsson S; Heitto M; Palomäki A; Suojanen K; Harjola VP
    Scand J Trauma Resusc Emerg Med; 2016 Oct; 24(1):125. PubMed ID: 27756354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloud-Based Influenza Surveillance System in Emergency Departments Using Molecular-Based Testing: Advances and Challenges.
    Shaw-Saliba K; Hansoti B; Burkom H; Martinez DA; DuVal A; Lee B; Chau P; McBride B; Hsieh YH; Sathananthan V; Persing D; Turnlund M; Shively R; Dugas A; Rothman RE
    West J Emerg Med; 2022 Feb; 23(2):115-123. PubMed ID: 35302441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geolocalization of Influenza Outbreak Within an Acute Care Population: A Layered-Surveillance Approach.
    Kannan VC; Hodgson N; Lau A; Goodin K; Dugas AF; LoVecchio F
    Ann Emerg Med; 2016 Nov; 68(5):618-626. PubMed ID: 27772674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two new generation influenza rapid diagnostic tests with instrument-based digital readout systems for influenza virus detection.
    Ryu SW; Lee JH; Kim J; Jang MA; Nam JH; Byoun MS; Lim CS
    Br J Biomed Sci; 2016 Jul; 73(3):115-120. PubMed ID: 27327199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of respiratory virus molecular testing in emergency departments and its association with patient care outcomes: a retrospective observational study across six Australian hospitals.
    Wabe N; Li L; Dahm MR; Lindeman R; Yimsung R; Clezy K; Thomas J; Varndell W; Westbrook J; Georgiou A
    BMJ Open; 2019 Aug; 9(8):e030104. PubMed ID: 31399462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Utility of On-Demand Multiplex Respiratory Pathogen Testing among Adult Outpatients.
    Green DA; Hitoaliaj L; Kotansky B; Campbell SM; Peaper DR
    J Clin Microbiol; 2016 Dec; 54(12):2950-2955. PubMed ID: 27654334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of influenza transmission in a hospital emergency department during the week of highest incidence.
    Esteve-Esteve M; Bautista-Rentero D; Zanón-Viguer V
    Emergencias; 2018 Feb; 30(1):7-13. PubMed ID: 29437304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential for early warning of viral influenza activity in the community by monitoring clinical diagnoses of influenza in hospital emergency departments.
    Zheng W; Aitken R; Muscatello DJ; Churches T
    BMC Public Health; 2007 Sep; 7():250. PubMed ID: 17877836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of the Quidel Sofia Fluorescent Immunoassay Compared With 2 Nucleic Acid Assays and Viral Culture to Detect Pandemic Influenza A(H1N1)pdm09.
    Arbefeville SS; Fickle AR; Ferrieri P
    Lab Med; 2015; 46(3):230-4. PubMed ID: 26199264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.